Author:
Mendyk Aleksander,Pacławski Adam,Szafraniec-Szczęsny Joanna,Antosik Agata,Jamróz Witold,Paluch Marian,Jachowicz Renata
Abstract
AbstractLow solubility of active pharmaceutical compounds (APIs) remains an important challenge in dosage form development process. In the manuscript, empirical models were developed and analyzed in order to predict dissolution of bicalutamide (BCL) from solid dispersion with various carriers. BCL was chosen as an example of a poor water-soluble API. Two separate datasets were created: one from literature data and another based on in-house experimental data. Computational experiments were conducted using artificial intelligence tools based on machine learning (AI/ML) with a plethora of techniques including artificial neural networks, decision trees, rule-based systems, and evolutionary computations. The latter resulting in classical mathematical equations provided models characterized by the lowest prediction error. In-house data turned out to be more homogeneous, as well as formulations were more extensively characterized than literature-based data. Thus, in-house data resulted in better models than literature-based data set. Among the other covariates, the best model uses for prediction of BCL dissolution profile the transmittance from IR spectrum at 1260 cm−1 wavenumber. Ab initio modeling–based in silico simulations were conducted to reveal potential BCL–excipients interaction. All crucial variables were selected automatically by AI/ML tools and resulted in reasonably simple and yet predictive models suitable for application in Quality by Design (QbD) approaches. Presented data-driven model development using AI/ML could be useful in various problems in the field of pharmaceutical technology, resulting in both predictive and investigational tools revealing new knowledge.
Funder
Jagiellonian University in Krakow
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference36 articles.
1. Pradhan R, Tran TH, Choi JY, Choi IS, Choi HG, Yong CS, et al. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability. Arch Pharm Res. 2015;38:522–33. https://doi.org/10.1007/s12272-014-0399-0.
2. Fridgeirsdottir GA, Harris R, Fischer PM, Roberts CJ. Support tools in formulation development for poorly soluble drugs. J Pharm Sci. 2016;105:2260–9. https://doi.org/10.1016/j.xphs.2016.05.024.
3. Antosik A, Witkowski S, Woyna-Orlewicz K, Talik P, Szafraniec J, Wawrzuta B, et al. Application of supercritical carbon dioxide to enhance dissolution rate of bicalutamide. Acta Pol Pharm. 2017;74:1231–8. https://doi.org/10.3390/pharmaceutics11030130.
4. Drugbank, https://www.drugbank.ca/drugs/DB01128. Accessed 30 October 2019.
5. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. FDA Guidance for industry. 2017, https://www.fda.gov/regulatory-information/search-fda-guidance-documents/waiver-vivo-bioavailability-and-bioequivalence-studies-immediate-release-solid-oral-dosage-forms. Accessed 30 October 2019.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献